BioCardia, Inc. 8-K

What Happened
On May 15, 2026, BioCardia, Inc. announced its financial results for the quarter ended March 31, 2026 and furnished a press release reporting those results as Exhibit 99.1 to the Form 8-K. The filing notifies investors that the company has published its quarterly earnings information; investors should review the press release for the specific revenue, expense, and cash‑position figures.

Key Details

• Announced and furnished press release dated May 15, 2026 covering the quarter ended March 31, 2026 (Exhibit 99.1).
• The Form 8-K entry was filed under Item 2.02 (Results of Operations and Financial Condition).
• The submission also includes the Inline XBRL cover page (Exhibit 104) for interactive financial data.

Why It Matters
Earnings and quarterly results provide the most direct, recent view of BioCardia’s revenue trends, costs, and cash position—key inputs for assessing near‑term viability and valuation. Retail investors should read the attached press release and any accompanying financial statements or XBRL data to see how the quarter compares with prior periods and analyst expectations, since those details can influence the stock price and investment decisions.